Westerkirk Capital Inc. Johnson & Johnson Transaction History
Westerkirk Capital Inc.
- $875 Billion
- Q3 2025
A detailed history of Westerkirk Capital Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Westerkirk Capital Inc. holds 35,059 shares of JNJ stock, worth $7 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
35,059
Previous 27,284
28.5%
Holding current value
$7 Million
Previous $4.17 Billion
55.98%
% of portfolio
0.74%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding JNJ
# of Institutions
4,831Shares Held
1.74BCall Options Held
19.8MPut Options Held
16.8M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...